— Company Raises 2023 Revenue and GAAP Net Income Expectations by Approximately $425 Million — — Conference Call Scheduled for Today at 8:00 a.m. ET — DUBLIN, June 6, 2023 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) today announced that on May 31, 2023 it received a final award (the Final Award) from the arbitral tribunal (the … Read more
— Dr. Loew to Assume New Leadership Role Upon Completion of the Planned Separation of Alkermes’ Oncology Business — — Planned Separation Remains on Track to be Completed in Second Half of 2023 — DUBLIN, June 1, 2023 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) today announced that Caroline J. Loew, Ph.D., has been appointed as the … Read more
Company Has Outperformed Peers and Relevant Indices Since Unveiling its December 2020 Value Enhancement Plan 70% of Board’s Independent Directors Have Been Appointed Over the Last Four Years, Including Four Directors Designated or Supported by Shareholders Company Launches www.AlkermesValue.com, Providing Additional Information for Shareholders Alkermes’ Board Recommends Shareholders Vote “FOR” Alkermes’ Director Nominees on Company’s … Read more